These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


137 related items for PubMed ID: 8709128

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The discovery of capsazepine, the first competitive antagonist of the sensory neuron excitants capsaicin and resiniferatoxin.
    Walpole CS, Bevan S, Bovermann G, Boelsterli JJ, Breckenridge R, Davies JW, Hughes GA, James I, Oberer L, Winter J.
    J Med Chem; 1994 Jun 24; 37(13):1942-54. PubMed ID: 8027976
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Autoradiographic visualization and pharmacological characterization of vanilloid (capsaicin) receptors in several species, including man.
    Szallasi A.
    Acta Physiol Scand Suppl; 1995 Jun 24; 629():1-68. PubMed ID: 8801775
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Resiniferatoxin binds to the capsaicin receptor (TRPV1) near the extracellular side of the S4 transmembrane domain.
    Chou MZ, Mtui T, Gao YD, Kohler M, Middleton RE.
    Biochemistry; 2004 Mar 09; 43(9):2501-11. PubMed ID: 14992587
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Functional properties of the high-affinity TRPV1 (VR1) vanilloid receptor antagonist (4-hydroxy-5-iodo-3-methoxyphenylacetate ester) iodo-resiniferatoxin.
    Seabrook GR, Sutton KG, Jarolimek W, Hollingworth GJ, Teague S, Webb J, Clark N, Boyce S, Kerby J, Ali Z, Chou M, Middleton R, Kaczorowski G, Jones AB.
    J Pharmacol Exp Ther; 2002 Dec 09; 303(3):1052-60. PubMed ID: 12438527
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Specific binding of resiniferatoxin, an ultrapotent capsaicin analog, by dorsal root ganglion membranes.
    Szallasi A, Blumberg PM.
    Brain Res; 1990 Jul 30; 524(1):106-11. PubMed ID: 2400923
    [Abstract] [Full Text] [Related]

  • 14. SAR studies of capsazepinoid bronchodilators. Part 1: The importance of the catechol moiety and aspects of the B-ring structure.
    Dalence-Guzmán MF, Berglund M, Skogvall S, Sterner O.
    Bioorg Med Chem; 2008 Mar 01; 16(5):2499-512. PubMed ID: 18065231
    [Abstract] [Full Text] [Related]

  • 15. Vanilloid (capsaicin) receptor in the rat: positive cooperativity of resiniferatoxin binding and its modulation by reduction and oxidation.
    Szallasi A, Lewin NA, Blumberg PM.
    J Pharmacol Exp Ther; 1993 Aug 01; 266(2):678-83. PubMed ID: 8355200
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Analogues of capsaicin with agonist activity as novel analgesic agents; structure-activity studies. 2. The amide bond "B-region".
    Walpole CS, Wrigglesworth R, Bevan S, Campbell EA, Dray A, James IF, Masdin KJ, Perkins MN, Winter J.
    J Med Chem; 1993 Aug 06; 36(16):2373-80. PubMed ID: 8360882
    [Abstract] [Full Text] [Related]

  • 18. Structure-activity relationships defining the ACD-tricyclic cannabinoids: cannabinoid receptor binding and analgesic activity.
    Melvin LS, Milne GM, Johnson MR, Wilken GH, Howlett AC.
    Drug Des Discov; 1995 Nov 06; 13(2):155-66. PubMed ID: 8872458
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Loss of TRPV1-expressing sensory neurons reduces spinal mu opioid receptors but paradoxically potentiates opioid analgesia.
    Chen SR, Pan HL.
    J Neurophysiol; 2006 May 06; 95(5):3086-96. PubMed ID: 16467418
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.